L

Lunit Inc
KOSDAQ:328130

Watchlist Manager
Lunit Inc
KOSDAQ:328130
Watchlist
Price: 39 250 KRW 0.13% Market Closed
Market Cap: 1.1T KRW

Lunit Inc
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Lunit Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
L
Lunit Inc
KOSDAQ:328130
Total Current Assets
â‚©230.4B
CAGR 3-Years
37%
CAGR 5-Years
44%
CAGR 10-Years
N/A
I
Infinitt Healthcare Co Ltd
KOSDAQ:071200
Total Current Assets
â‚©188.5B
CAGR 3-Years
19%
CAGR 5-Years
21%
CAGR 10-Years
15%
U
UBCare Co Ltd
KOSDAQ:032620
Total Current Assets
â‚©58B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
4%
L
LifeSemantics Corp
KOSDAQ:347700
Total Current Assets
â‚©38.2B
CAGR 3-Years
12%
CAGR 5-Years
75%
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Total Current Assets
â‚©25.8B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
C
CJ Bioscience Inc
KOSDAQ:311690
Total Current Assets
â‚©62.9B
CAGR 3-Years
-1%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

Lunit Inc
Glance View

Market Cap
1.1T KRW
Industry
Health Care

Lunit Inc., founded in South Korea, stands as a pioneering force in the application of artificial intelligence within the realm of medical technology. As a company at the intersection of healthcare and cutting-edge AI, Lunit crafts advanced solutions that enhance the diagnostic processes in radiology and oncology. The company's name, derived from "learning unit," underscores its mission to employ deep learning as a core component in transforming medical diagnostics. At the heart of Lunit’s operations are their flagship products, Lunit INSIGHT and Lunit SCOPE, which are designed to empower physicians by providing highly accurate diagnostic readings and treatment predictions. With this technology, Lunit aims to reduce diagnostic errors and improve the efficiency of medical imaging analysis, ultimately enhancing patient treatment outcomes. Lunit generates revenue through strategic partnerships and sales of their AI software solutions to hospitals and healthcare providers globally. The company's business model involves not only licensing its AI technologies but also integrating them with existing medical imaging equipment, thus enhancing the value derived from traditional diagnostic tools. By collaborating with prominent medical device manufacturers and healthcare institutions, Lunit ensures both the scalability and adaptability of its products in diverse clinical settings. Additionally, they actively engage in research collaborations and pilot programs to further their technological advancements and expand their market presence. Through these endeavors, Lunit is steadily carving out a crucial role in the healthcare sector by offering AI-driven solutions that promise to revolutionize patient care.

Intrinsic Value
14 867.12 KRW
Overvaluation 62%
Intrinsic Value
Price
L

See Also

What is Lunit Inc's Total Current Assets?
Total Current Assets
230.4B KRW

Based on the financial report for Dec 31, 2024, Lunit Inc's Total Current Assets amounts to 230.4B KRW.

What is Lunit Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
44%

Over the last year, the Total Current Assets growth was 0%. The average annual Total Current Assets growth rates for Lunit Inc have been 37% over the past three years , 44% over the past five years .

Back to Top